Treatment of Primary CNS Lymphoma: Maximizing Clinical Benefit, Minimizing Neurotoxicity
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology
Link
https://link.springer.com/content/pdf/10.1007/s11912-021-01116-9.pdf
Reference78 articles.
1. Hoffman S, Propp JM, McCarthy BJ. Temporal trends in incidence of primary brain tumors in the United States, 1985–1999. Neuro-Oncol. 2006;8:27–37. https://doi.org/10.1215/S1522851705000323.
2. Ostrom QT, Cioffi G, Gittleman H, Patil N, Waite K, Kruchko C, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012–2016. Neuro-Oncol. 2019;21:v1-100. https://doi.org/10.1093/neuonc/noz150.
3. Villano JL, Koshy M, Shaikh H, Dolecek TA, McCarthy BJ. Age, gender, and racial differences in incidence and survival in primary CNS lymphoma. Br J Cancer. 2011;105:1414–8. https://doi.org/10.1038/bjc.2011.357.
4. Coté TR, Manns A, Hardy CR, Yellin FJ, Hartge P. Epidemiology of brain lymphoma among people with or without acquired immunodeficiency syndrome. AIDS/Cancer Study Group. J Natl Cancer Inst 1996;88:675–9. https://doi.org/10.1093/jnci/88.10.675.
5. Taylor JW, Flanagan EP, O’Neill BP, Siegal T, Omuro A, Deangelis L, et al. Primary leptomeningeal lymphoma: International Primary CNS Lymphoma Collaborative Group report. Neurology. 2013;81:1690–6. https://doi.org/10.1212/01.wnl.0000435302.02895.f3.
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Bifunctional iRGD-Exo-DOX crosses the blood-brain barrier to target central nervous system lymphoma;Biochemical Pharmacology;2024-05
2. Challenges in the management of primary central nervous system lymphoma;Critical Reviews in Oncology/Hematology;2023-08
3. Central Nervous System Lymphoma: The Great Mimicker—A Single-Institution Retrospective Study;Case Reports in Oncological Medicine;2023-05-16
4. Spatial single cell analysis of tumor microenvironment remodeling pattern in primary central nervous system lymphoma;Leukemia;2023-04-29
5. Systemic Relapse in a Young Adult Patient with Primary CNS Diffuse Large B-Cell Lymphoma;Case Reports in Hematology;2022-06-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3